Cargando…
Tocotrienols are good adjuvants for developing cancer vaccines
BACKGROUND: Dendritic cells (DCs) have the potential for cancer immunotherapy due to their ability to process and present antigens to T-cells and also in stimulating immune responses. However, DC-based vaccines have only exhibited minimal effectiveness against established tumours in mice and humans....
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824713/ https://www.ncbi.nlm.nih.gov/pubmed/20051142 http://dx.doi.org/10.1186/1471-2407-10-5 |